Genotoxic activity and induction of biotransformation enzymes in two human cell lines after treatment by Erika fuel extract

Environmental Toxicology and Pharmacology

Volumn 23, Issue 1, 2007, Pages 89-95

  Amat Bronnert, Agnès ^a   Castegnaro, Marcel ^b   Pfohl Leszkowicz, Annie ^a  

^a LABORATOIRE DE GÉNIE CHIMIQUE   (France)

^b NONE

Author keywords

Cytochrome P450; DNA adduct; Erika oil spill; HePG2

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; CYCLOOXYGENASE 2; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; ERIKA FUEL EXTRACT; LEUKOTRIENE B4;

ARTICLE; BIOTRANSFORMATION; BRONCHUS MUCOSA; CARCINOGENESIS; CONTROLLED STUDY; DNA ADDUCT; ENZYME METABOLISM; GENOTOXICITY; HEPATOMA CELL; HUMAN; HUMAN CELL; INFLAMMATION; INHALATION; PRIORITY JOURNAL; RADIOACTIVITY;

EID: 33845366549     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2006.07.006     Document Type: Article

References (58)

1. Amat A., Castegnaro M., Burgeot T., and Pfohl-Leszkowicz A. DNA adducts as a biomarker of pollution-field study on the genotoxic impact evolution of the Erika oil spill on mussels (Mytilus edulis) over an eleven months period. Polycyclic Aromat. Compd. 24 (2004) 713
2. Amat A., Castegnaro M., and Pfohl-Leszkowicz A. Genotoxic activity of thiophenes on human cell line (HEPG2). Polycyclic Aromat. Hydrocarbon 24 (2004) 733
3. Amat A., Burgeot T., Castegnaro M., and Pfohl-Leszkowicz A. Genotoxic impact of ERIKA fuel (Fuel No. 2) on fish liver (Solea solea). In: Lichtfouse E., Schwartzbauer J., and Robert D. (Eds). Environmental Chemistry: Green Chemistry and Pollutant in Ecosystems (2005), Springer-verlag, Heidelberg 743
4. Amat A., Burgeot T., Castegnaro M., and Pfohl-Leszkowicz A. DNA adducts in fish following an oil spill exposure. Environ. Chem. Lett. 4 (2006) 93-99
5. Bahkle Y.S. COX-2 and cancer: a new approach to an old problem. Br. J. Pharmacol. 134 (2001) 1137
6. Boudet, C., Chemin, F., Bois, F., 2000. Evaluation du risque sanitaire de la marée noire consécutive au naufrage de l'ERIKA, rapport 6. Institut national de l'environnement industriel et des risques, Ministère de l'Aménagement du Territoire et de l'Environnement, Unité d'Evaluation des Risques Sanitaires, Direction des Risques Chroniques.
7. Brandon E.F.A., Raap C.D., Meijerman I., Beihen J.H., and Schellens J.H.M. An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons. Toxicol. Appl. Pharmacol. 198 (2003) 233
8. Chang T.K.H., Chen J., Pillay V., Ho J.Y., and Stelvio B. Real time polymerase chain reaction analysis of CYP1B1 gene expression in human liver. Toxicol. Sci. 71 (2003) 11
9. Conney A.H. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons, G.H.A. Clowes Memorial Lecture. Cancer Res. 42 (1982) 4875-4917
10. Degen G.H. Prostaglandin-H synthase containing cell lines as tools for studying metabolism and toxicity of xenobiotics. Toxicology 82 (1993) 243
11. Diamond L., Kruzeswki F., Aden D.P., Knowles B.B., and Baird W.M. Metabolic activation of benzo(a)pyrene by a human hepatoma cell line. Carcinogenesis 1 (1980) 871
12. Dipple A., and Bigger C.A.H. Mechanism of action of food-associated polycyclic aromatic hydrocarbon carcinogens. Mutat. Res. 259 (1991) 263
13. El Adlouni C., Pinelli E., Azemar B., Zaoui D., Beaune P., and Pfohl-Leszkowicz A. Phenobarbital increases DNA adduct and metabolites formed by ochratoxin A: role of CYP 2C9 and microsomal glutathione-S-transferase. Environ. Mol. Mutagen. 35 (2000) 123
14. Eling T.E., Thompson D.C., Foreman G.L., Curtis J.F., and Hugues M.F. Prostaglandin H synthase and xenobiotics. Annu. Rev. Pharmacol. Toxicol. 30 (1990) 1
15. Gelboin H.V. Benzo[a]pyrene metabolism, activation, and carcinogenesis: role and regulation ofmixed-function oxidases and related enzymes. Physiol. Rev. 60 (1980) 1107
16. Genevois C., Pfohl-Leszkowicz A., Boillot K., Brandt H., and Castegnaro M. Implication of cytochrome P-450 1A isoforms and the AH receptor in the genotoxicity of coal-tar fume condensate and bitumen fume condensates. Environ. Toxicol. Pharmacol. 5 (1998) 283
17. Guengerich F., Chun Y.J., Kim D., Gillam E.M.J., and Shimada T. Cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies. Mutat. Res. 523-524 (2003) 173
18. Henke D., Danilowicz R.M., Curtis J.F., Eling R.C., and Eling T.E. Metabolism of arachidonic acids by human nasal and bronchial epithelia cells. Arch. Biochem. Biophys. 268 (1998) 426
19. Hukkanen, J., 2000. Xenobiotic-metabolizing cytochrome P450 enzymes in human lung, vol. 621. Department of Toxicology and Pharmacology. University of Oulu. Ph.D. Thesis, p. 69.
20. IARC, 1989. Occupational exposures in petroleum refining crude oil and major petroleum fuels, vol. 45. International Agency for Research on Cancer, monographs on the evaluation of carcinogenic risks to humans. Lyon, France.
21. Iwanari M., Nakajima M., Kizu R., Hayakawa K., and Yokoi T. Induction of CYP1A1, CYP1A2 et CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences. Arch. Toxicol. 76 (2002) 287
22. Janot F.B., Massaad H., Ribrag V., De Waziers I., Beaune P., Luboinski B., et al. Principal xenobiotic-metabolizing enzyme systems in human head and neck squamous cell carcinoma. Br. J. Cancer 81 (1993) 1279
23. Jurànek I., Suzuki H., and Yamamoto S. Affinities of various mammalian arachidonate lipoxygenases and cyclooxygenases of molecular oxygen as substrate. Biochim. Biophys. Acta 1436 (1999) 509
24. Khan K.N.M., Knapp D.W., Denicola D.B., and Harris R.K. Expression of cyclooxygenase 2 in transitional cell carcinoma of the urinary bladder in dogs. Am. J. Vet. Res. 61 (2000) 478
25. Kelley D.J., Mestre J.R., Subramaniak K., Sacks P.G., Schantz S.P., Tanate T., et al. Benzo[a]pyrene up-regulates cyclooxygenase-2 gene expression in oral epithelial cells. Carcinogenesis 18 (1997) 795
26. Knasmüller S., Parzefall W., Sanyal R., Ecker S., Schwab C., Uhl M., Mersch-Sundermann V., Williamson G., Hietsch G., Langer T., Darroudi F., and Natarajon A.T. Use of metabolically competent human hepatoma cells for the detection of mutagens and antimutagens. Mutat. Res. 402 (1998) 185
27. Knasmüller S., Mersch-Sundermann V., Kevekerdes S., Darroudi F., Huber W.W., Hoelzl C., Bichler J., and Majer B. Use of human-derived cell lines for the detection of environmental & dietary genotoxicants current state of knowledge. Toxicology 198 (2004) 315-328
28. Kress S., and Greenlee W.F. Cell specific regulation of human CYP1A1 and CYP1B1 genes. Cancer Res. 57 (1997) 1264-1269
29. Maceâ K., Bowman E.D., Vautravers P., Shields P.G., Harris C.C., and Pfeifer A.M.A. Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues. Eur. J. Cancer 34 (1998) 914
30. Majima M., Amano H., and Hayashi I. Prostanoid receptor signalling relevant to tumor growth and angiogenesis. Trends Pharmacol. Sci. 24 (2003) 624
31. Mauderly J.L. Toxicological approaches to complex mixtures. Environ. Health Perspect. 101 Suppl. 4 (1993) 155
32. Mazeas L., and Budzinski H. Polycyclic aromatic hydrocarbon 13C/12C ratio measurement in petroleum and marine sediments: application to standard reference materials and a sediment suspected of contamination from the Erika oil spill. J. Chromatogr. A 923 (2001) 165
33. Mc Fadyen M.C.E., Rooney P.H., Melvin W.T., and Murray G.I. Quantitative analysis of the Ah receptor/cytochrome P450 CYP1B1/CYP1A1 signalling pathway. Biochem. Pharmacol. 65 (2003) 1663
34. Mohan S., and Epstein J.B. Carcinogenesis and cyclooxygenase: the potential role of COX-2 inhibition in upper aerodigestive tract cancer. Oral Oncol. 39 (2003) 537
35. O'Brien P.J. Peroxidases. Chem. Biol. Interact. 129 (2000) 113
36. Otto S., Mareus C., Pidgeon C., and Jefcoate C. A novel adrenocoeticotropin-inducible cytochrome P450 from rat adrenal microsomes catalyses polycyclic aromatic hydrocarbon metabolism. Endocrinology 129 (1991) 970
37. Pelkonen O., and Nebert D.W. Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacol. Rev. 34 (1982) 189
38. Pfohl-Leszkowicz A., Chakor K., Creppy E.E., and Dirheimer G. DNA-adducts formation and variation of DNA-methylation after treatment of mice with ochratoxin A. In: Castegnaro M., Plestina R., Dirheimer G., Chernozemsky I.N., and Bartsch H. (Eds). Mycotoxins, Endemic Nephropathy and Urinary Tracts Tumours vol. 115 (1991), IARC Scientific Public, Lyon 245
39. Pfohl-Leszkowicz A., and Castegnaro M. Further arguments in favour of direct covalent binding of Ochratoxin A (OTA) after metabolic biotransformation. Food Addit. Contam. Suppl. 1 (2005) 75
40. Phillips D.H., and Castegnaro M. Standardization and validation of DNA adduct postlabelling methods: report of interlaboratory trials and production of recommended protocols. Mutagenesis 14 (1999) 301
41. Poirier M.C., and Beland F.A. DNA adduct measurements and tumour incidence during chronic carcinogen exposure in animals models: implication for DNA adduct based human cancer risk assessment. Chem. Res. Toxicol. 5 (1992) 749
42. Prescott M., and Fitzpatrick F.A. Cyclooxygenase-2 and carcinogenesis. Biochim. Biophys. Acta 1470 (2000) M69
43. 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis 7 (1986) 1543
44. Sassa S., Sugita O., Galbraith R.A., and Kappas A. Drug metabolism by the human hepatoma cell HepG2. Biochem. Biophys. Res. Commun. 143 (1987) 52
45. Savas U., and Jefcoat C.R. Dual regulation of cytochrome P450 EF expression via the aryl hydrocarbon receptor and protein stabilisation in C3/10T1/2 cells. Mol. Pharmacol. 45 (1994) 1153
46. Shimada T., Hayes C.L., Yamazaki H., Amin S., Hecht S.S., Guengerich F.P., and Sutter T.R. Activation of chemically of diverse of diverse procarcinogenes by human cytochrome P 450 1B1. Cancer Res. 56 (1996) 2979
47. Shimada T., El Bayoumy K., Sutter T.R., Guengerich F.P., and Yamazaki H. Roles of human cytochrome P450s 1A1, 1A2, 1B1, 2E1, and 3A4/5/7 in the activation of environmental procarcinogens and promutagens. Mutat. Res. 379 (1997) S6
48. Shimada T., and Fujii-Kuriyama Y. Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1. Cancer Sci. 95 (2004) 1
49. Shimada T., and Guengerich F.P. Inhibition of human cytochrome P450 1A1-, 1A2- and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons. Chem. Res. Toxicol. 19 (2006) 288
50. Stankova J., and Rola-Pleszczynski M. Leukotriene B4 stimulates c-fos and c-jun gene transcription and AP-1 binding activity in human monocytes. Biochem. J. 282 (1992) 625
51. Uhl M., Helma C., and Knasmüller S. Single-cell gel electrophoresis assays with human-derived hepatoma (Hep G2) cells. Mutat. Res. 441 (1999) 215
52. Vakharia D.P., Lui N., Pause R., Fasco M., Bessette E., Zhang G.Y., and Kaminsky S.L. Polycyclic aromatic hydrocarbon/metal mixtures: effect on PAH induction of CYP1A1 in human HEPG2 cells. Drug Metab. Dispos. 29 (2001) 999
53. Vakharia D.P., Lui N., Pause R., Fasco M., Bessette E., Zhang G.Y., and Kaminsky S.L. Effects of metals on polycyclic aromatic induction of CYP1A1 and CYP1A2 in human hepatocyte cultures. Toxicol. Appl. Pharmacol. 170 (2001) 93
54. Valentin-Severin I., Le Hegarat L., Lhuguenot J.C., Le Bon A.M., and Chagnon M.C. Use of HepG2 cell line for direct or indirect mutagens screening: comparative investigation between comet and micronucleus assays. Mutat. Res. 536 (2003) 79
55. Wattenberg L.W. Chemoprevantion of cancer. Cancer Res. 45 (1985) 1
56. Williams C.S., Mann M., and Dubour N. The role of cyclooxygenase in inflammation, cancer and development. Oncogen 18 (1999) 7908-7916
57. Yang S.K., and Silverman B.D. Polycyclic Aromatic Hydrocarbon Carcinogenesis: Structure-Activity Relationships vol. I/II (1988), CRC Press, Boca Raton, FL pp. 213/210
58. Zhang Z., Fasco M.J., Huang Z., Guengerich F.P., and Kaminsky L.S. Human cytochromes P450 1A1 and P4501A2: R-warfarin metabolism as a probe. Chem. Biol. Interact. 124 (1995) 173